BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20671642)

  • 1. Endovascular brachytherapy with (192)Ir and (188)Re to treat de novo and recurrent infrainguinal restenoses.
    Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):573-8. PubMed ID: 20671642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular brachytherapy in the femoropopliteal segment using 192Ir and 188Re.
    Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
    Cardiovasc Intervent Radiol; 2008; 31(4):698-708. PubMed ID: 18185955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endovascular brachytherapy (EVBT) with Rhenium-188 for restenosis prophylaxis after angioplasty of infrainguinal lesions: early experience].
    Leissner GG; Wengenmair H; Sciuk J; Woelfle KD; Winterstein A; Weinrich K; Bohndorf K; Wohlgemuth WA
    Rofo; 2011 Aug; 183(8):735-42. PubMed ID: 21800265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis.
    Pokrajac B; Pötter R; Maca T; Fellner C; Mittlböck M; Ahmadi R; Seitz W; Minar E
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):923-31. PubMed ID: 11072147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial.
    Krueger K; Landwehr P; Bendel M; Nolte M; Stuetzer H; Bongartz R; Zaehringer M; Winnekendonk G; Gossmann A; Mueller RP; Lackner K
    Radiology; 2002 Aug; 224(2):519-28. PubMed ID: 12147851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions.
    Zehnder T; von Briel C; Baumgartner I; Triller J; Greiner R; Mahler F; Do DD
    J Endovasc Ther; 2003 Apr; 10(2):304-11. PubMed ID: 12877614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience.
    Schopohl B; Leirmann D; Pohlit LJ; Heyd R; Strassmann G; Bauersachs R; Schulte-Huermann D; Rahl CG; Manegold KH; Kollath J; Bottcher HD
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):835-40. PubMed ID: 8960510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging.
    Wyttenbach R; Gallino A; Alerci M; Mahler F; Cozzi L; Di Valentino M; Badimon JJ; Fuster V; Corti R
    Circulation; 2004 Aug; 110(9):1156-61. PubMed ID: 15326071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular brachytherapy in the prevention of vascular restenosis.
    Dvorák J; Fridrich J; Raupach J; Petera J; Krajina A; Lojík M; Masková J; Vodnanský P; Zoul Z; Odrázka K; Kalousová D; Chovanec V
    Cardiovasc Radiat Med; 2001; 2(3):130-2. PubMed ID: 11786317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: resuscitation of endovascular brachytherapy owing to improved logistics.
    Minar E
    J Endovasc Ther; 2012 Aug; 19(4):476-9. PubMed ID: 22891825
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
    Gallino A; Do DD; Alerci M; Baumgartner I; Cozzi L; Segatto JM; Bernier J; Tutta P; Kellner F; Triller J; Schneider E; Amann-Vesti B; Studer G; Jäger K; Aschwanden M; Canevascini R; Jacob AL; Kann R; Greiner R; Mahler F
    J Endovasc Ther; 2004 Dec; 11(6):595-604. PubMed ID: 15615549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose rate endovascular brachytherapy in aorto-iliac lesion for the prevention of restenosis.
    Yamazaki H; Tomoda K; Shiomi H; Maeda M; Kawata S; Okada A; Murakami T; Nakamura H; Tanaka E; Inoue T; Inoue T
    Radiat Med; 2002; 20(1):25-32. PubMed ID: 12002600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular brachytherapy and restenosis following lower limb angioplasty: Systematic review and meta-analysis of randomized clinical trials.
    Mitchell D; O'Callaghan AP; Boyle EM; Kavanagh EG; Walsh SR
    Int J Surg; 2012; 10(3):124-8. PubMed ID: 22349154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience.
    Wolfram RM; Budinsky AC; Pokrajac B; Potter R; Minar E
    Radiology; 2005 Jul; 236(1):338-42. PubMed ID: 15955854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time.
    Diehm N; Silvestro A; Do DD; Greiner R; Triller J; Mahler F; Baumgartner I
    J Endovasc Ther; 2005 Dec; 12(6):723-30. PubMed ID: 16363902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update.
    Liermann D; Kirchner J; Bauernsachs R; Schopohl B; Böttcher HD
    Herz; 1998 Sep; 23(6):394-400. PubMed ID: 9816526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study.
    Pokrajac B; Schmid R; Kirisits C; Mock U; Fellner C; Wambersie A; Pötter R; Minar E
    Radiother Oncol; 2002 Apr; 63(1):97-102. PubMed ID: 12065109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endovascular Ir-192 HDR brachytherapy for avoidance of intimal hyperplasia in peripheral vessels after PTA and stent implantation. A 6-year experience].
    Böttcher HD; Schopohl B
    Strahlenther Onkol; 1998 Mar; 174(3):115-20. PubMed ID: 9524619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five year follow-up after brachytherapy for restenosis in peripheral arteries.
    Liermann DD; Bauernsachs R; Schopohl B; Böttcher HD
    Semin Interv Cardiol; 1997 Jun; 2(2):133-7. PubMed ID: 9546994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravascular brachytherapy in the prevention of vascular restenosis].
    Dvorák J; Petera J; Fridrich J; Raupach J; Krajina A; Hůlek P; Melichar B; Malý J
    Cas Lek Cesk; 2003 Mar; 142(3):154-6. PubMed ID: 12756843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.